Error: Could not add to watchlist. X

Carnegie Fund II - Biotechnology Sub-Fund

+ Watchlist
CARBIOA:LX
22.46
EUR
As of 00:00:00 ET on 02/08/2016.
Fund Type
SICAV
52Wk Range
22.46 - 41.76
1 Yr Return
-32.90%
YTD Return
-32.39%
52Wk Range
22.46 - 41.76
1 Yr Return
-33.43%
YTD Return
-32.39%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 02/08/2016)
22.46
Total Assets (m EUR) (on 01/29/2016)
24.072
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 26.20 k 2.89 m 8.73
Gilead Sciences Inc 29.60 k 2.78 m 8.40
Vertex Pharmaceuticals Inc 21.50 k 2.50 m 7.55
Biogen Inc 8.36 k 2.36 m 7.14
Regeneron Pharmaceuticals Inc 2.93 k 1.47 m 4.44
Medivation Inc 32.14 k 1.42 m 4.30
BioMarin Pharmaceutical Inc 14.39 k 1.39 m 4.21
Alexion Pharmaceuticals Inc 7.65 k 1.34 m 4.07
Cempra Inc 43.83 k 1.25 m 3.79
Mylan NV 24.44 k 1.23 m 3.71
Profile
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
ADDRESS
c/o Carnergie Fund Services SA
P.O. BOX 1141
L-1011 Luxembourg
Luxembourg
PHONE
352-40-40-30-1